Source: Annual Congress 2006 - In vivo and in vitro aspects of lung injury



Rating:

Share or cite this content

Citations should be made in the following way:
B. Egemnazarov, A. Sydykov, R. T. Schermuly, N. Weissmann, W. Seeger, F. Grimminger, H. A. Ghofrani (Giessen, Germany). sGC activator BAY 412272 attenuates ischemia/reperfusion injury of the lung. Eur Respir J 2006; 28: Suppl. 50, 4740

Member's Comments

No comment yet.

Related content which might interest you: Role of eNOS in ischemia/reperfusion-induced lung injury Source: Eur Respir J 2007; 30: Suppl. 51, 293s Year: 2007 Effect of phosphodiesterase-4 inhibitor on the inflammation, oxidative damage and apoptosis in a saline lavage-induced model of acute lung injury Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Rho-kinase inhibitor ameliorates bleomycin-induced chronic lung injury in neonatal rats Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care Year: 2011 The stimulator of soluble guanylate cyclase riociguat protects against bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Gabexate mesilate attenuates ischemia-reperfusion injury of lung grafts via the inhibition of neutrophil activation Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005 Effect of curcumin on LPS-induced neutrophil activation and acute lung injury Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation Year: 2012 ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin Source: Eur Respir J 2008; 31: 363-371 Year: 2008 Soluble guanylyl cyclase expression is reduced in acute lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 398s Year: 2006 Effects of curcumin or dexamethasone on lung ischaemia-reperfusion injury in rats Source: Eur Respir J 2009; 33: 398-404 Year: 2009 Endothelial- but not leukocytic-NOX2 mediates vascular injury in ischemia/reperfusion syndrome of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 822s Year: 2006 Endothelin-1 receptor antagonist prevents hyperoxia-induced parenchymal mechanical impairment in mice Source: Eur Respir J 2004; 24: Suppl. 48, 334s Year: 2004 Role of thrombin-activatable fibrinolysis inhibitor in lipopolysaccharide-induced acute lung injury Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Ghrelin attenuates lipopolysaccharide-induced acute lung injury Source: Eur Respir J 2005; 26: Suppl. 49, 731s Year: 2005 Effects of phosphodiesterase inhibitors on the lung functions in a saline lavage-induced model of acute lung injury Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents Year: 2017 Kallistatin protects against LPS-induced mouse lung injury Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 PD98059 attenuates the development of bleomycin-induced lung injury and fibrosis Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment Source: Eur Respir J 2012; 40: 416-423 Year: 2012 Combined inhibition of NADPH oxidase and inducible NOS in prevention of ischemia/reperfusion injury of the lung Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Angiopoietin-1 variant, COMP-Ang1 attenuates hydrogen peroxide-induced acute lung injury Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Creatine supplementation inhibits acute lung injury induced by pulmonary ischemia-reperfusion Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010